UNIVERSIDAD DE OVIEDO

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 495
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9072757 Combination of an HMG-CoA reductase inhibitor and a farnesyl-pyrophosphate synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteinsJun 19, 13Jul 07, 15[A61K]
8598132 Glycosylated indolocarbazoles, method for obtaining same and uses thereofApr 06, 09Dec 03, 13[A61K, C07H, C12P, C12N]
8518914 HMG-CoA reductase and farnesyl-pyrophosphate synthase inhibitors for the treatment of conditions related to prenylated proteins in cellsJul 05, 07Aug 27, 13[A61K]
8426169 Glycosylate derivatives of mithramycin, method of preparation and uses thereofFeb 04, 08Apr 23, 13[A61K, C07H, C12P]
8207321 Method of obtaining idolocarbazoles using biosynthetic rebeccamycin genesOct 17, 02Jun 26, 12[C07H, C12P, C12N]
7423008 Derivatives of mithramycin and methods of making and uses thereofMar 10, 04Sep 09, 08[A01N]
6677120 Building blocks for the solution phase synthesis of oligonucleotidesMar 30, 01Jan 13, 04[C07H, C12Q, C12P]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0105,352 COMBINATION OF AN HMG-COA REDUCTASE INHIBITOR AND A FARNESYL-PYROPHOSPHATASE SYNTHASE INHIBITOR FOR THE TREATMENT OF DISEASES RELATED TO THE PERSISTENCE AND/OR ACCUMULATION OF PRENYLATED PROTEINSAbandonedDec 18, 14Apr 16, 15[A61K]
2011/0207,705 OVIEDOMYCIN DERIVATIVES, METHOD FOR OBTAINING SAME AND USE THEREOFAbandonedMar 26, 09Aug 25, 11[A61K, C12P, C12N, C07C, A61P]
2009/0124,019 ABSOLUTE METHOD FOR THE QUANTIFICATION OF ORGANIC COMPOUNDSAbandonedOct 11, 06May 14, 09[G01N]
7521458 Spiropiperidylrifamycins for the treatment of mycobacterial infectionsExpiredJul 04, 05Apr 21, 09[A61K, C07D, A61P]
2007/0059,689 Hybrid glycosylated products and their production and useAbandonedNov 29, 02Mar 15, 07[C07H, C12Q, C12P, C07K]
6969767 Optically active carbonates as precursors of (+)-zopicloneExpiredApr 02, 03Nov 29, 05[C07D]
6800473 Human cathepsin L2 protein, gene encoding said protein and use thereofExpiredApr 13, 99Oct 05, 04[A61K, C12Q, C12P, C12N, C07K]
2004/0167,163 Optically pure paroxetine precursorsAbandonedDec 18, 03Aug 26, 04[A61K, C07D]
2004/0038,250 Gene cluster for thienamycin biosynthesis, genetic manipulation and utilityAbandonedFeb 26, 03Feb 26, 04[C12Q, C12N]
2003/0172,560 Ear tag adaptable device for taking samples to identify cattle by means of dnaAbandonedMay 22, 03Sep 18, 03[G09F]
2003/0018,048 Optically pure paroxetine precursorsAbandonedJul 10, 02Jan 23, 03[A61K, C07D]
2002/0001,840 Methods and compositions for modulating integrin-mediated cell-cell interactionsAbandonedApr 02, 01Jan 03, 02[C07H, A61K, C12N]
2001/0056,246 Visual optical device for the control of halitosisAbandonedJan 17, 01Dec 27, 01[G01N, A61B]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.